New program aims to keep patients with opioid and meth use on track after hospital discharge
NCT ID NCT06027814
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tests a program called MIAPP that combines a patient navigator, a smartphone app, and small rewards to help people who use both opioids and methamphetamine stay connected to addiction treatment after leaving the hospital. About 40 adults who started buprenorphine while hospitalized will be randomly assigned to get the program plus usual care or usual care alone. The goal is to see if the program improves treatment attendance and medication adherence over 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Harborview Medical Center
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.